The estimated Net Worth of Grainne Quinn is at least $770 Tisíc dollars as of 6 March 2024. Grainne Quinn owns over 4,008 units of Perrigo plc stock worth over $594,689 and over the last 8 years he sold PRGO stock worth over $175,561. In addition, he makes $0 as Executive Vice President a Chief Medical Officer at Perrigo plc.
Grainne has made over 15 trades of the Perrigo plc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 4,008 units of PRGO stock worth $116,192 on 6 March 2024.
The largest trade he's ever made was exercising 5,011 units of Perrigo plc stock on 8 October 2019 worth over $260,271. On average, Grainne trades about 1,446 units every 131 days since 2016. As of 6 March 2024 he still owns at least 22,248 units of Perrigo plc stock.
You can see the complete history of Grainne Quinn stock trades at the bottom of the page.
Dr. Grainne Quinn, M.D., is Executive Vice President, Chief Medical Officer of the Company. Dr. Quinn was named Executive Vice President in July 2016 and has served as Chief Medical Officer since November 2015. Prior to that she served as Vice President and Head of Global Patient Safety from January 2014 until November 2015. Dr. Quinn was Vice President and Head of Global Pharmacovigilance and Risk Management for Elan from April 2009 until December 2013 when the Company acquired Elan.
Grainne Quinn is 50, he's been the Executive Vice President a Chief Medical Officer of Perrigo plc since 2016. There are 27 older and 1 younger executives at Perrigo plc. The oldest executive at Perrigo Company plc is Rolf Classon, 75, who is the Independent Director.
Grainne's mailing address filed with the SEC is PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen a Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
Perrigo plc executives and other stock owners filed with the SEC include: